Investors

Corporate News

TR-1 Notification of Major Interest in Shares

24 March 2017

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
   
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
Quantum Pharma Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached  
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments  
An event changing the breakdown of voting rights  
Other (please specify): Type 1 disclosure as per the Transparency Directive II Regulation Yes
3. Full name of person(s) subject to the
notification obligation:
Legal & General Investment Management Limited (LGIM)
4. Full name of shareholder(s) 
(if different from 3.)
Legal & General Assurance Society Limited
(LGAS)
5. Date of the transaction and date on
which the threshold is crossed or
reached:
22 March 2017
6. Date on which issuer notified: 24 March 2017
7. Threshold(s) that is/are crossed or
reached:
LGIM (Above 15%)

8. Notified details:
A: Voting rights attached to shares
Class/type of
shares

if possible using
the ISIN CODE
Situation previous
to the triggering
transaction
Resulting situation after the triggering transaction
Number
of
Shares
Number
of
Voting
Rights
Number
of shares
Number of voting
rights
% of voting rights
Direct Direct Indirect Direct Indirect
Ordinary GB00BRTL8Q42 LGIM
25,342,135
25,409,135 25,409,135 15.02%

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Expiration
date
Exercise/
Conversion Period
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
% of voting
rights
         

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Exercise price Expiration date Exercise/
Conversion period
Number of voting rights instrument refers to % of voting rights
Nominal Delta
             

Total (A+B+C)
Number of voting rights Percentage of voting rights
LGIM
25,409,135
15.02%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
Legal & General Group Plc (Direct and Indirect) (Group) ( 25,409,135 -15.02% = Total Position)


Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect)  ( 25,409,135 -15.02% = Total Position)


Legal & General Investment Management Limited (Indirect) (LGIM) ( 25,409,135 -15.02% = Total Position)
Legal & General (Unit Trust Managers) Limited ( 16,517,092 -9.76%= UTM)


Legal & General Group Plc (Direct) (L&G) ( 8,892,043 - 5.25%=LGAS, & PMC)
Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD) 
Legal & General Insurance Holdings Limited (Direct) (LGIH)
Legal & General Assurance (Pensions Management) Limited  (PMC) 
Legal & General Assurance Society Limited  (LGAS)
 
Proxy Voting:
10. Name of the proxy holder: n/a
11. Number of voting rights proxy holder will cease to hold: n/a
12. Date on which proxy holder will cease to hold
voting rights:
n/a
 
13. Additional information: Notification using the total voting rights figure of  169,117,640
14. Contact name: Victoria Davies (LGIM)
15. Contact telephone number: 029 2035 4147

 

back to Corporate News

 
Quantum Pharmaceuticals
UL Medicines
Quantum Aseptics
PERN Consumer Products
PROTOMED